{"cik":"0001534120","ticker":"AVTX","name":"Avalo Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-05-11","last_filing_date":"2026-05-12","url":"/sec/cik-0001534120","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-220002","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-05-12","title":"SCHEDULE 13G — Avalo Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001534120/schedule-13g/0001193125-26-220002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1534120/0001193125-26-220002-index.html"}],"related_endpoints":{"profile":"/sec/AVTX/profile","timeline":"/sec/AVTX/timeline","peers":"/sec/AVTX/peers","insider_pulse":"/sec/AVTX/insider-pulse","insider_summary":"/sec/AVTX/insider-summary","insider_transactions":"/sec/AVTX/insider-transactions","form144":"/sec/AVTX/form144","holdings_as_filer":"/sec/AVTX/holdings","financial_facts":"/sec/AVTX/financial-facts","derivatives":"/sec/AVTX/derivatives","officers":"/sec/AVTX/officers","insider_network":"/sec/AVTX/insider-network","risk_flags":"/sec/AVTX/risk-flags","filings":"/sec/AVTX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=AVTX"}}